NCT01441622View on ClinicalTrials.gov

Evaluation of a New Medical Device AL539 in Patients With Obstructive Apneas Sleep Syndrome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Obstructive Sleep Apnea Syndrome
Interventions
DEVICE

AL539 (SRETT)

recording data with AL539 (SRETT)

Trial Locations (1)

75181

Hôpital Hôtel DIEU - Centre du sommeil et de la Vigilance, Paris

Sponsors

Collaborators (1)

Atlanstat
All Listed Sponsors
collaborator

Atlanstat

INDUSTRY

lead

Air Liquide Santé International

INDUSTRY

NCT01441622 - Evaluation of a New Medical Device AL539 in Patients With Obstructive Apneas Sleep Syndrome | Biotech Hunter | Biotech Hunter